Trial intelligence / Profile preview

Sunitinib in Advanced Renal Cell Carcinoma Without Prior Nephrectomy

NCT00663559Phase 2Completed

Sponsor
SOGUG
Start
Feb 2008
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by SOGUG. Started Feb 2008; status: completed.

02

Drugs

sunitinib
03

Conditions

renal cell carcinoma (RCC)

Beyond the preview

Go deeper on NCT00663559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00663559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call